Skip to content
Zenlabs Ethica logo

Zenlabs Ethica

530697 BSE
₹26.87

Close ·

P/E
Not meaningful: loss-making over the last twelve months
View as Markdown
MCP
Close 4 Nov 2026 ₹26.87 −5.13 −16.0% 1Y
Start ₹32.00

Key Fundamentals

MicrocapCommercial ServicesServices

Price-based figures at the close · EPS basis: Standalone · TTM

ROCE
5.07%
Debt to Equity
1.29
EPS (TTM)
−₹3.91
Book Value
₹13.08
Market Cap
—
P/E (TTM)
Not meaningful: loss-making over the last twelve months
P/B
2.05
ROE
0.21%
Dividend Yield
0.96%
EBITDA
₹2.00 Cr
52W High
₹39.99
52W Low
₹16.50

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

52 Average

Data confidence 91/100

Category scores

Quality
54
Average
Returns, margins, earnings quality 22% weight
Valuation
61
Good
Cheap vs sector & own history 24% weight
Growth
42
Weak
Sales & profit trajectory 9% weight
Financial Health
12
Poor
Solvency, leverage, coverage 9% weight
Momentum
75
Strong
Trend strength, vol-adjusted 12% weight
Ownership
50
Average
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

No strengths listed

Weaknesses

5
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -3.70% over past five years.
  • Company has a low return on equity of 2.39% over last 3 years.
  • Company might be capitalizing the interest cost
  • Promoter holding has decreased over last 3 years: -6.16%

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallBearish964
OscillatorsBearish261
Moving AveragesStrong Bearish703

Key readings

RSI (14)
48.85
Neutral
MACD (12,26,9)
−0.63
Bearish
SMA (50)
28.01
Bearish
SMA (200)
26.39
Bullish

As of

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
10Y+12.01%
5Y−3.70%
3Y−11.15%
1Y−8.75%
TTM−1.82%

Net profit

Net profit growth by window
10YTurned to loss
5YTurned to loss
3YTurned to loss
1YTurned to loss
TTMTurned to loss

Operating cash flow

Operating cash flow growth by window
10Y+16.00%
5YTurned positive
3Y+38.75%
1Y+6.01%
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y+2.49 pp
5Y+0.73 pp
3Y−0.53 pp
1Y−1.20 pp
TTM−3.06 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹78.73 Cr
Mar 2018₹69.85 Cr
Mar 2019₹65.37 Cr
Mar 2020₹58.50 Cr
Mar 2021₹56.64 Cr
Mar 2022₹69.09 Cr
Mar 2023₹66.89 Cr
Mar 2024₹58.56 Cr
Mar 2025₹51.42 Cr
Mar 2026₹46.92 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹0.95 Cr
Mar 2018₹1.16 Cr
Mar 2019₹1.26 Cr
Mar 2020−₹0.73 Cr
Mar 2021₹0.77 Cr
Mar 2022₹0.78 Cr
Mar 2023₹0.49 Cr
Mar 2024₹0.42 Cr
Mar 2025₹0.27 Cr
Mar 2026−₹1.94 Cr

Quarterly Results

₹ Cr
530697 quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
13.57
14.06
15.6
15.33
12.36
13.35
12.72
12.99
11.48
12.43
12.43
10.58
14.18
Expenses
13.04
13.62
14.91
14.57
11.74
12.73
12.04
12.33
10.93
11.98
11.91
10.31
14.47
Operating Profit
0.53
0.44
0.69
0.76
0.62
0.62
0.68
0.66
0.55
0.45
0.52
0.27
−0.29
OPM %
3.91%
3.13%
4.42%
4.96%
5.02%
4.64%
5.35%
5.08%
4.79%
3.62%
4.18%
2.55%
−2.05%
Other Income
0.05
0.22
0
0.02
0
0
0
0.04
0
0.06
−2.08
0.12
0
Interest
0.16
0.21
0.22
0.25
0.23
0.23
0.24
0.23
0.21
0.19
0.23
0.18
0.16
Depreciation
0.32
0.32
0.32
0.33
0.32
0.31
0.32
0.31
0.29
0.24
0.23
0.14
0.11
PBT
0.1
0.13
0.15
0.2
0.07
0.08
0.12
0.16
0.05
0.08
−2.02
0.07
−0.56
Tax %
30%
30.77%
26.67%
25%
42.86%
25%
33.33%
43.75%
20%
50%
0%
114.29%
3.57%
Net Profit
0.07
0.09
0.11
0.15
0.04
0.05
0.09
0.09
0.03
0.04
−2.01
0
−0.57
EPS (₹)
0.11
0.14
0.17
0.23
0.06
0.08
0.14
0.14
0.05
0.06
−3.09
0
−0.88

Profit & Loss

₹ Cr
530697 profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
0
15.09
78.73
69.85
65.37
58.5
56.64
69.09
66.89
58.56
51.42
46.92
49.62
Expenses
0.05
14.89
77.28
68
63.28
59.2
54.89
66.7
63.98
56.15
48.84
45.13
48.67
Operating Profit
−0.05
0.2
1.45
1.85
2.09
−0.7
1.75
2.39
2.91
2.41
2.58
1.79
0.95
OPM %
—
1.33%
1.84%
2.65%
3.2%
−1.2%
3.09%
3.46%
4.35%
4.12%
5.02%
3.82%
1.91%
Other Income
0
−0.03
0.08
0.1
0.1
0.05
0.11
0.09
−0.45
0.3
0.04
−1.9
−1.9
Interest
0
0.02
0.1
0.09
0.07
0.23
0.29
0.37
0.53
0.83
0.93
0.81
0.76
Depreciation
0.01
0.06
0.2
0.2
0.23
0.29
0.71
0.89
1.25
1.29
1.26
0.89
0.72
PBT
−0.06
0.09
1.23
1.66
1.89
−1.17
0.86
1.22
0.68
0.59
0.43
−1.81
−2.43
Tax %
16.67%
−88.89%
21.95%
29.52%
32.8%
−36.75%
10.47%
36.07%
26.47%
27.12%
37.21%
6.63%
—
Net Profit
−0.07
0.17
0.95
1.16
1.26
−0.73
0.77
0.78
0.49
0.42
0.27
−1.94
−2.54
EPS (₹)
−0.18
0.26
1.46
1.78
1.94
−1.12
1.18
1.2
0.75
0.65
0.41
−2.98
−3.91
Div. Payout %
0%
0%
16.32%
0%
0%
0%
0%
0%
33.21%
0%
0%
0%
—

Balance Sheet

₹ Cr
530697 balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
3.62
6.2
6.2
6.2
6.51
6.51
6.51
6.51
6.51
6.51
6.51
6.51
Reserves
−1.65
−1.41
−0.41
0.81
1.77
0.9
2.05
2.82
3.19
3.61
3.92
2
Borrowings
0
1.09
0.96
0.85
0.6
0.73
2.6
3.9
5.85
14.86
12.71
10.98
Other Liabilities
1.77
24.49
26.62
21.96
26.01
25.85
21.04
24.66
27.95
15.28
17.48
17.71
Total Liabilities
3.74
30.37
33.37
29.82
34.89
33.99
32.2
37.89
43.5
40.26
40.62
37.2
Fixed Assets
0.06
1.68
1.5
1.33
1.36
1.12
3.51
3.53
5.03
3.7
2.29
1.87
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
Investments
0
1.25
0.95
0.7
0.7
0.7
0.7
0.7
0.7
0.7
0.7
0
Other Assets
3.68
27.44
30.92
27.79
32.83
32.17
27.99
33.66
37.77
35.86
37.63
35.33
Total Assets
3.74
30.37
33.37
29.82
34.89
33.99
32.2
37.89
43.5
40.26
40.62
37.2

Cash Flow

₹ Cr
530697 cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0.02
0.92
−1.06
0.36
0.8
0.45
−8.41
−0.38
1.52
−9.06
3.83
4.06
Investing
0
−1.69
−0.02
−0.03
−0.22
0.01
0.15
0
−1.47
0.11
0.14
0
Financing
0
3.23
−0.27
−0.23
−0.14
−0.03
−0.52
0.31
0.06
8.24
−3.08
−2.95
Net Cash Flow
0.02
2.47
−1.35
0.09
0.44
0.43
−8.78
−0.07
0.11
−0.71
0.88
1.11
Free Cash Flow
0.02
−0.77
−1.08
0.33
0.49
0.4
−8.35
−0.41
−0.03
−9.08
3.96
4.06
CFO/OP
−40
460
−73
19
38
−64
−475
−11
62
−371
157
234

Ratios

530697 financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
—
398
108
126
139
139
122
110
118
129
139
122
Inventory Days
—
250
34.42
11.12
31.23
33.95
40.46
56.05
77.85
100
128
161
Days Payable
—
665
136
126
161
165
150
141
174
101
140
165
Cash Conversion Cycle
—
−17.7
5.66
11.64
9.33
7.4
11.85
24.32
22.21
128
127
118
Working Capital Days
—
4.84
13.4
21.95
28.42
24.02
27.97
35.34
34.98
47.31
52.74
39.44
ROCE %
−2.99%
9.94%
21.06%
23.96%
24.13%
−11.05%
12.02%
13.04%
12.44%
7.01%
5.69%
5.07%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Zenlabs Ethica insights

59 extracted metrics across FY09–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 52.96%
  • Public 38.60%
  • Others 8.44%

No promoter shares pledged as of 14 Oct 2026

Change since Jun 2026

Documents

Frequently Asked Questions about Zenlabs Ethica

What does Zenlabs Ethica Ltd do?
Incorporated in 1993, Zenlabs Ethica Ltd deals in marketing and distribution of pharmaceutical products.
Where is Zenlabs Ethica Ltd (ZENLABS) listed?
Zenlabs Ethica Ltd trades under code 530697 on the BSE.
Which sector does Zenlabs Ethica Ltd belong to?
Zenlabs Ethica Ltd is classified under the Commercial Services sector, in the Diversified Services industry.
What is the 52-week high and low of Zenlabs Ethica Ltd?
Over the last 52 weeks Zenlabs Ethica Ltd has traded between ₹16.5 and ₹39.99 as of 4 Nov 2026.
Does Zenlabs Ethica Ltd pay dividends?
Zenlabs Ethica Ltd has a dividend yield of 0.96%.
What is the Return on Equity (ROE) of Zenlabs Ethica Ltd?
Zenlabs Ethica Ltd reported a return on equity of 0.21%. Its debt-to-equity ratio is 1.29.

Company Information

Incorporated in 1993, Zenlabs Ethica Ltd deals in marketing and distribution of pharmaceutical products.

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/530697.md for Zenlabs Ethica Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More